Vividion Therapeutics
Vividion is seeking a highly motivated biotransformation expert to drive drug discovery and development programs through metabolite profiling, identification, and enzymology. The role involves designing and executing in vitro and in vivo MetID studies, managing CRO-conducted research, and providing scientific advisory support to project teams. The position requires interpreting mass spectra, preparing regulatory documentation, and mentoring the in-house DMPK team.
We are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with devastating diseases not
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vividion Therapeutics.
Right around the average for this role
Senior Scientist, Biotransformation
Bristol Myers Squibb
Principal Scientist - Biotransformation/Metabolic Identification
Inotiv
Biotransformation Scientist
Inotiv
Research Advisor, Biotransformation Scientist
Eli Lilly and Company
Associate Director, Discovery DMPK – In Vitro ADME
pharmaron
Preclinical Drug Metabolism and Pharmacokinetic (DMPK) Project Lead - Respiratory & Immunology (R&I)
AstraZeneca